← FDA DRUG APPROVALS

FDA ANDA · ANDA203106

KLOR-CON

Sponsor: UPSHER SMITH LABS

APPLICATION
ANDA203106
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-10
LATEST ACTION
2015-07-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

KLOR-CONDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL
KLOR-CONDiscontinued
POTASSIUM CHLORIDE 8MEQ · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

2015-07-10UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →